微生态调节剂及其在肝病治疗中的应用

Microecological Regulating Agents and Their Application in Treatment of Hepatopathy

微生态调节剂的开发与研究受到人们的普遍重视。肝炎后肝硬化患者肠道中的有益菌(双岐杆菌等)减少或消失,大肠杆菌等增加并转为优势菌,导致血内毒素升高。肠道菌群紊乱与肝功能损害程度密切相关。因此,正确使用微生态调节剂可以维护肝硬化患者的肠道微生态平衡,减少内毒素的产生与吸收。

The researches and developments of microecological regulating agents have widely received attention increasingly. The decrease and disappearance of beneficial bacteria number(as bifidobcteria) in the intestinal tract in patients with posthepatitic cirrhosis resultin increase of E. coli, which changes as the documinant bacteria, which may lead to raise of endotoxin in the blood. The intastinal flora disturbance is closely related with the impairing degree of the hepatic function. So that the intestinal microecological balance will be safeguarded by the correct use of microecological regulating agents, the decrease of production and absorption of the endotoxin will act as a active stabilizing factor for disease.